1.
Janku F, Petruzelka L, Pribylová O, Vedralova J, Honova H, Pecen L, et al. Efficacy of weekly trastuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes. Radiol Oncol [Internet]. 2002 Jun. 1 [cited 2026 Sep. 1];36(2). Available from: https://www.radioloncol.com/index.php/ro/article/view/1403